eCite Digital Repository

Short-chain naphthoquinone protects against both acute and spontaneous chronic murine colitis by alleviating inflammatory responses

Citation

Shastri, S and Shinde, T and Woolley, KL and Smith, JA and Gueven, N and Eri, R, Short-chain naphthoquinone protects against both acute and spontaneous chronic murine colitis by alleviating inflammatory responses, Frontiers in Pharmacology, 12 pp. 1-16. ISSN 1663-9812 (2021) [Refereed Article]


Preview
PDF (Published version)
4Mb
  

Copyright Statement

Copyright 2021 Shastri, Shinde, Woolley, Smith, Gueven and Eri. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) License (https://creativecommons.org/licenses/by/4.0/).

DOI: doi:10.3389/fphar.2021.709973

Abstract

Ulcerative colitis (UC) is characterised by chronic, relapsing, idiopathic, and multifactorial colon inflammation. Recent evidence suggests that mitochondrial dysfunction plays a critical role in the onset and recurrence of this disease. Previous reports highlighted the potential of short-chain quinones (SCQs) for the treatment of mitochondrial dysfunction due to their reversible redox characteristics. We hypothesised that a recently described potent mitoprotective SCQ (UTA77) could ameliorate UC symptoms and pathology. In a dextran sodium sulphate- (DSS-) induced acute colitis model in C57BL/6J mice, UTA77 substantially improved DSS-induced body weight loss, disease activity index (DAI), colon length, and histopathology. UTA77 administration also significantly increased the expression of tight junction (TJ) proteins occludin and zona-occludin 1 (ZO-1), which preserved intestinal barrier integrity. Similar responses were observed in the spontaneous Winnie model of chronic colitis, where UTA77 significantly improved DAI, colon length, and histopathology. Furthermore, UTA77 potently suppressed elevated levels of proinflammatory cytokines and chemokines in colonic explants of both DSS-treated and Winnie mice. These results strongly suggest that UTA77 or its derivatives could be a promising novel therapeutic approach for the treatment of human UC.

Item Details

Item Type:Refereed Article
Keywords:cytokines, endoplasmic reticulum stress, inflammatory bowel disease, naphthoquinones, tight junction proteins
Research Division:Biomedical and Clinical Sciences
Research Group:Pharmacology and pharmaceutical sciences
Research Field:Pharmaceutical sciences
Objective Division:Expanding Knowledge
Objective Group:Expanding knowledge
Objective Field:Expanding knowledge in the biomedical and clinical sciences
UTAS Author:Shastri, S (Mrs Sonia Shastri)
UTAS Author:Shinde, T (Ms Tanvi Shinde)
UTAS Author:Woolley, KL (Miss Krystel Woolley)
UTAS Author:Smith, JA (Associate Professor Jason Smith)
UTAS Author:Gueven, N (Dr Nuri Guven)
UTAS Author:Eri, R (Associate Professor Raj Eri)
ID Code:146158
Year Published:2021
Deposited By:Pharmacy
Deposited On:2021-08-23
Last Modified:2021-09-08
Downloads:4 View Download Statistics

Repository Staff Only: item control page